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With the aid of immunohistochemical methods the localization of the various isoenzymes of glutathione S-transferase was investigated. The a
isoenzyme was present solely in the proximal tubular cells of the human kidney, while the it form was restricted to the distal convoluted tubules, the
thin loop of Henle, and the collecting ducts. Damage to the epithelial cell membranes results in the increased excretion of these enzymes with the
urine. The cx and t isoenzymes have been isolated in a highly purified form and used for the production of polyclonal antisera. Subsequently, radioim-
munological and ELISA techniques were developed for quantitation of these proteins in the urine; the methods exhibited a high specificity and were
sufficiently sensitive to determine nanogram quantities or less. Disease affecting tubular function, cyclosporine A treatment, administration of
nephrotoxic antibiotics, and exposure to cadmium all resulted in characteristic changes in the pattern of the glutathione transferase isoenzymes pre-
sent in urine. Such effects were seen also in patients who had previously been exposed to nephrotoxic agents, but in whom conventional tests for
kidney function were apparently normal. Thus, it appears that radioimmunologic or immunochemical quantitation of a and ic forms of the enzyme
can be used as sensitive and relatively simple markers for the early detection of toxic effects with respect to the renal tubuli. Environ Health
Perspect 102(Suppl 3):293-296 (1994).
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Introduction
In several organs-mainly heart and -
liver-cell damage is followed by release of ~~*7
a number of cytoplasmic enzymes to the
blood, a phenomenon that provides the
basis for clinical diagnosis ofheart and liver 1.Ia
disease. Although attempts in this direction
have been made previously using, for exam-
ple, the Tamm-Horsfall glycoprotein, cor- ,.
responding assays for kidney damage have, W*
for various reasons, had little success (1)..
Three major classes of human isoen- OWi
zymes of glutathione S-transferases(ic g-
andin, GST) have been identified; ac, it, t;4i
and Soh Human kidney contains the 8 4 and4 obta in eila co
forms in relatively high amounts. Although
there have been some peiuatmts to....,~
use GST as a marker ofkidney damage (2/),. ~ ~
earlier methods have not been sufficiently
specific and sensitive to be clinically func- 0
This paper was presented at the Second International ...Z Meeting on Molecular Mechanisms of Metal Toxicity
and Carcinogenicity held 10-17 January 1993 in
Madonna de Campiglio, Italy. ' 4, ..*..
This proiect has been supported by the National
Swedish Chemicals Inspectorate and the Swedish Figure 1. Immunohistochemical staining of a human kidney biopsy forax and it glutathione S-transferases. Formalin-
AdRessac CuciforrEspndencertonDr RobenerNisso fixed slices were incubated with the antiserum, and the antigen-antibody complex visualized by the peroxidase-antiper-
Department of Genetic and Cellular Toxicology, oxidase technique (61. (A) Antiserum against human liver a-GST was used. Staining was only found in the proximal
Wallenberg Laboratory, University of Stockholm, convoluted tubular epithelium. (B) Antiserum against human placental it GST was employed. Positive reaction was
Stockholm, Sweden. Telephone 46 8 839 784. Fax 46 obtained in epithelial cells of the thin segments of the loop of Henle, the distal convoluted tubules and the collecting
87357698. ducts. Magnification x 550.
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Figure2. ELISAtitration ofpurified a- and t-GST. (A): a-GST; (B): it-GST
tional. The aim of our investigations has iza
been to study the localization ofthe a and Localizati
x isoenzymes ofGST in the kidney, isolate antiperox
the proteins in pure form, and develop histologi(
radioimmunologic and immunochemical antibody
methods to be employed as sensitive and GST is f
relatively simple markers for the assessment tubuli (F
of toxic effects on the human kidney (Figure 1
(3-5). is localize
and the
Experimenltal lecting d
Isolation of the a and isoenzymes of
GST from human liver and placenta, the RIAand
production and purification of polyclonal Using es
antibodies in rabbit, development of RIA was
immunochemical procedures for quantita- Routine
tion, and clinical diagnosis and selection of regularly
patients have been described elsewhere in urine. A.
detail (3-5). ELISA fc
PurificationofGST oped. Th
Highly purified a and isoenzymes were that quz
obtained by using chromatographic proce- ng/ml is
dures involving affinity chromatography antibodi
with hexylglutathione coupled to epoxy- the titrat
activated Sepharose as the ligand as a final
step. Upon chromatography the purified Speafi
proteins behaved as single components of The spec
27,000 and 25,000 Da for the a and it with resi
isoenzymes, respectively. and p, a
100.
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tiOn in theKidney
-ion, as visualized by the peroxidase-
xidase method (6), was studied in
ical sections using the appropriate
(4). In fresh kidney biopsies, oc
found exclusively in the proximal
qigure 1A), whereas the Xt enzyme
.B), absent from this tubular section,
ed to the distal convoluted tubulus
thin loops of Henle and the col-
Lucts.
iELISA
tablished principles, a competitive
developed for both GST proteins.
measurements could be performed
in the range 2 to 1000 ng/ml in
.n even more sensitive solid-phase
or both isoenzymes was also devel-
he titration curves for the a (Figure
I t-GST (Figure 2B) demonstrate
antitation down to around 0.5
;feasible. The high quality of the
es is indicated by the steep slope of
tion curves.
lity
cificity of the antibodies was tested
pect to the three isoenzymes, a, it,
.nd with regard to other proteins
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Figure 4. Stability of st-GST in human urine. A) Urine samples stored at4°C or20°C priorto measurement. B) Urine
samples stored atpH 5.3, 7.0, and 8.5(20QC).
Figure3.Western blotanalysis ofcytosolic proteinsfrom
human tissues with antibodies for a- and P-GST. (A)
Reaction with antibodies towards a-GST. Lane 1, liver;
lane 2, kidney; lane 3, lung; lane 4, adrenals; and lane 5,
standard (mixture of purified a- and ir-GST). (B) Reaction
with antibodies against it-GST. Lanes lto 5 as described
for(A).
that may be present in human urine, such
as albumin, fibrinogen, prothrombin,
hemoglobin and P-2-microglobulin. As can
be seen from Table 1, the antisera of a and
x proteins, reacted exclusively with the cor-
responding enzyme with no detectable
cross-reactivity.
The same was true for several other
tested proteins and enzymes. The specificity
could also be confirmed by employing
Western blot analysis of the cytosol pre-
pared from various human organs. Figures
3A and 3B demonstrate that each antibody
only reacts with one single protein band,
also in preparations from tissues in which
both isoenzymes are present. The band
width is proportional to the relative levels
of the isoenzymes present in liver, kidney,
lung, and adrenals, respectively.
Stability
Samples kept in the refrigerator at 40 C for
5 days showed no significant decrease in
enzyme content (Figure4A). Storage at room
temperature resulted in a gradual decrease,
but after 5 days 35% ofthe original amount
could still be detected. As seen in Figure 4B,
stability at room temperature is not appre-
Table 1. Specificity of the RIA technique for a and it
isoenzymes ofGST.
Cross reaction
Protein % ofn-GSTa % ofa-GST
GST, n 100 0.3
GST, a 0.2 100
GST, p 0.3 0.4
Albumin 0.2 0.2
Fibrinogen 0.4 0.4
Prothrombin 0.1 0.2
Hemoglobin 0.3 0.4
p-2-microglobulin 0.1 0.2
aThe values for a and it-GST were taken as 100%. The
values presented arethe means ofthree experiments.
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Figure 5. Effectofaminoglycoside antibiotictreatment on
urinary a-GST. Netilmycin was given intravenously at a
dose of 100 mg/24 hr (2 mg/kg body weight). (solid line,
urinary a-GST; broken line, serum creatinine level.
ciably affected by pH in the range 5.3 to
8.5. The a GST exhibited similar stability
characteristics.
DrugNephrotoxicity
The utility of GST isoenzymes as markers
for kidney damage was initially studied in
patients who had undergone kidney trans-
plantation. In normal healthy adults about
6 ng/ml of the it protein is found in the
urine, whereas the amount ofthe a enzyme
is hardly measurable (Table 2). Rejection
after transplantation greatly increased the
excretion of7t enzyme in the urine without
affecting the levels ofthe a protein.
The drug Cyclosporine A (CsA), used
as immunosuppressive agent in association
with renal transplantation, as well as several
aminoglycoside antibiotics are known to
Table2. Glutathione S-transferase levels in urine of nor-
mal individuals and in patientswith kidney disease.
a-GST, ir-GST,
Patients ng/ml urinea ng/ml urinea
Controls 0.6 5.9
Rejection after 0.9 20.5
transplantation
Cyclosporin A 6.2 6.3
nephrotoxicity
Tubular necrosis 21.3 246
(acuteform)
Renal infarct 148 808
aMean values(n=11-49).
induce tubular damage (7). Upon treat-
ment with CsA, considerable amounts of
ax-GST are found in the urine, while i-
GST remains unaffected. As expected,
renal infarction, which destroys various
types of kidney tissue, results in a more
than 100-fold increase of both enzymes in
the urine. Figure 5 shows the levels of a-
GST in a patient treated with the amino-
glycoside Netilmycin. After treatment for 5
days, the enzyme concentration in the
urine was increased 15-fold. However, no
changes in the serum creatinine level could
be observed.
HeavyMetalNephrotoxicity
Preliminary studies of cohorts of workers
exposed to nephrotoxic heavy metals have
indicated that quantitation ofGST proteins
in the urine constitute a valuable diagnostic
tool. In Figure 6 the t-GST levels have
been recorded in 15 accumulator workers
who had been exposed to cadmium by
inhalation 5 to 10 years previously, and
who at the time of our investigation were
diagnosed as clinically healthy using con-
ventional criteria. However, in comparison
with the control group, a continued
increased excretion of the tubular marker,
a-GST, was still evident.
Currently, workers in Sweden and
Poland with a history of exposure to high
levels of lead, cadmium, and mercury are
being investigated to characterize the dose-
response relationship for exposure to
nephrotoxic heavy metals as well as the
resulting changes in the GST isoenzyme
pattern in urine.
Discussion
In the case oftubular dysfunction, the mea-
surement of plasma proteins like P-2-
microglobulin and the retinol-binding
protein (a-2-microglobulin) have so far
provided the most sensitive indices oftubu-
lar damage. The instability, especially in
acid urine, constitutes the main problem
with assays based on ,-2-microglobulin.
Although the retinol-binding protein is
more stable, it is not a constitutive protein
ofthe kidney, but is synthesized in liver; its
presence in urine onlyprovides indirect evi-
dence of tubular damage (1). The persis-
tence ofsigns oftubular damage in humans
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Figure 6. a-GST levels in Swedish workers with a 6to 14
year history of cadmium exposure. Exposure to cadmium
ceased 4 to 8 years prior to measurement. When assayed
they were clinically diagnosed as healthy. Controls repre-
sentage-matched nonexposed individuals.
in whom cadmium exposure had been
stopped many years before is consistent
with previous observations based on deter-
mination ofP-2-microglobulin in cadmium
exposed workers (8). Our investigations
have demonstrated that the determination
of the isoenzymes of GST using RIA and
ELISA techniques provides a reliable and
sensitive alternative to conventional meth-
ods. The most important advantages ofthis
technique are: x and 7i GST isoenzymes
are constitutive proteins ofthe kidney. The
markers are stable in urine. The method is
simple, sensitive and reproducible. Due to
selective localization ofthe two isoenzymes,
differential diagnosis is possible.
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